Human papillomavirus infection among women with cytological abnormalities in Switzerland investigated by an automated linear array genotyping test

Journal of Medical Virology

Volumn 83, Issue 8, 2011, Pages 1370-1376

  Dobec, Marinko ^a   Bannwart, Fridolin ^a   Kilgus, Sandra ^a   Kaeppeli, Franz ^a   Cassinotti, Pascal ^a  

^a Medica   (Switzerland)

Author keywords

Automated Linear Array HPV test; HPV molecular epidemiology; HPV typing

Indexed keywords

VIRUS DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOMATION; BLOOD SAMPLING; CONTROLLED STUDY; FEMALE; GENOTYPE; HIGH RISK PATIENT; HUMAN; HUMAN CELL; HUMAN TISSUE; LESIONS AND DEFECTS; MAJOR CLINICAL STUDY; NONHUMAN; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTION; PREVALENCE; SCREENING; SQUAMOUS CELL; SWITZERLAND; UTERINE CERVIX; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY;

ADOLESCENT; ADULT; AGED; DNA, VIRAL; FEMALE; GENOTYPE; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; SWITZERLAND; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; YOUNG ADULT;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16;

EID: 79959224624     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.22126     Document Type: Article

References (30)

1. Agresti A, Coull BA. 1998. Approximate is better than "exact" for interval estimation of binomial proportions. Am Stat 52: 119-126.
2. Arbyn M, Anttila A, Jordan J, Ronco G, Schenck U, Segnan N, Wiener H, Herbert A, von Karsa L. 2010. European guidelines for quality assurance in cervical cancer screening. Second edition-summary document. Ann Oncol 21: 448-458.
3. Benard VB, Eheman CR, Lawson HW, Blackman DK, Anderson C, Helsel W, Thames SF, Lee NC. 2004. Cervical screening in the National Breast and Cervical Cancer Early Detection Program, 1995-2001. Obstet Gynecol 103: 564-571.
4. Bundesamt für Gesundheit. 2010. Die HPV-Impfprogramme in der Schweiz: Eine Synthese von 2007 bis 2010. Bull BAG 43: 949-953.
5. Castle PE, Fetterman B, Poitras N, Lorey T, Shaber R, Kinney W. 2009. Five-year experience of human papillomavirus DNA and Papanicolaou test cotesting. Obstet Gynecol 113: 595-600.
6. Clifford GM, Smith JS, Plummer M, Muñoz N, Franceschi S. 2003. Human papillomavirus types in invasive cervical cancer worldwide: A meta-analysis. Br J Cancer 88: 63-73.
7. Clifford GM, Rana RK, Franceschi S, Smith JS, Gough G, Pimenta JM. 2005. Human papillomavirus genotype distribution in low-grade cervical lesions: Comparison by geographic region and with cervical cancer. Cancer Epidemiol Biomarkers Prev 14: 1157-1164.
8. Cobo F, Concha Á, Ortiz M. 2009. Human papillomavirus (HPV) type distribution in females with abnormal cervical cytology. A correlation with histological study. Open Virol J 3: 60-66.
9. Coste J, Cochand-Priollet B, de Cremoux P, Le Galès C, Cartier I, Molinié V, Labbé S, Vacher-Lavenu MC, Vielh P, French Society of Clinical Cytology Study Group. 2003. Cross sectional study of conventional cervical smear, monolayer cytology, and human papillomavirus DNA testing for cervical cancer screening. BMJ 326: 733.
10. De Sanjosé S, Diaz M, Castellsagué X, Clifford G, Bruni L, Muñoz N, Bosch FX. 2007. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: A meta-analysis. Lancet Infect Dis 7: 453-459.
11. Del Prete R, Di Taranto AM, Lipsi MR, Nirchio V, Antonetti R, Miragliotta G. 2008. Prevalence and genotypes identification of human papillomavirus infection in a population of South Italy. J Clin Virol 42: 211-214.
12. Dobec M, Bannwart F, Kaeppeli F, Cassinotti P. 2009. Automation of the Linear Array HPV Genotyping Test and its application for routine typing of human papillomaviruses in cervical specimens of women without cytological abnormalities in Switzerland. J Clin Virol 45: 23-27.
13. Halfon P, Benmoura D, Khiri H, Penaranda G, Blanc B, Riggio D, Sandri MT. 2010. Comparison of the clinical performance of carcinogenic HPV typing of the Linear Array and Papillocheck HPV-screening assay. J Clin Virol 47: 38-42.
14. Herrero R. 1996. Epidemiology of cervical cancer. J Natl Cancer Inst Monogr 21: 1-6.
15. Iftner T, Eberle S, Iftner A, Holz B, Banik N, Quint W, Straube AN. 2010. Prevalence of low-risk and high-risk types of human papillomavirus and other risk factors for HPV infection in Germany within different age groups in women up to 30 years of age: An epidemiological observational study. J Med Virol 82: 1928-1939.
16. Jones HW III. 1995. Impact of the Bethesda System. Cancer 76: 1914-1918.
17. Khan MJ, Castle PE, Lorincz AT, Wacholder S, Sherman M, Scott DR, Rush BB, Glass AG, Schiffman M. 2005. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J Natl Cancer Inst 97: 1072-1079.
18. Meijer CJ, Berkhof J, Castle PE, Hesselink AT, Franco EL, Ronco G, Arbyn M, Bosch FX, Cuzick J, Dillner J, Heideman DA, Snijders PJ. 2009. Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older. Int J Cancer 124: 516-520.
19. Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KV, Snijders PJ, Meijer CJ, International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. 2003. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348: 518-527.
20. Paavonen J, Naud P, Salmerón J, Wheeler CM, Chow SN, Apter D, Kitchener H, Castellsague X, Teixeira JC, Skinner SR, Hedrick J, Jaisamrarn U, Limson G, Garland S, Szarewski A, Romanowski B, Aoki FY, Schwarz TF, Poppe WA, Bosch FX, Jenkins D, Hardt K, Zahaf T, Descamps D, Struyf F, Lehtinen M, Dubin G, Greenacre M, HPV Study PATRICIA Group. 2009. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): Final analysis of a double-blind, randomised study in young women. Lancet 374: 301-314.
21. Pannier-Stockman C, Segard C, Bennamar S, Gondry J, Boulanger JC, Sevestre H, Castelain S, Duverlie G. 2008. Prevalence of HPV genotypes determined by PCR and DNA sequencing in cervical specimens from French women with or without abnormalities. J Clin Virol 42: 353-360.
22. Panotopoulou E, Tserkezoglou A, Kouvousi M, Tsiaousi I, Chatzieleftheriou G, Daskalopoulou D, Magiakos G. 2007. Prevalence of human papillomavirus types 6, 11, 16, 18, 31, and 33 in a cohort of Greek woman. J Med Virol 79: 1898-1905.
23. Petignat P, Faltin D, Goffin F, Billieux MH, Stucki D, Sporri S, Vassilakos P. 2005. Age-related performance of human papillomavirus testing used as an adjunct to cytology for cervical carcinoma screening in a population with a low incidence of cervical carcinoma. Cancer 105: 126-132.
24. Ronco G, Cuzick J, Pierotti P, Cariaggi MP, Dalla Palma P, Naldoni C, Ghiringhello B, Giorgi-Rossi P, Minucci D, Parisio F, Pojer A, Schiboni ML, Sintoni C, Zorzi M, Segnan N, Confortini M. 2007. Accuracy of liquid based versus conventional cytology: Overall results of new technologies for cervical cancer screening: Randomised controlled trial. BMJ 335: 28.
25. Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. 2007. Human papillomavirus and cervical cancer. Lancet 370: 890-897.
26. Smith JS, Lindsay L, Hoots B, Keys J, Franceschi S, Winer R, Clifford GM. 2007. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: A meta-analysis update. Int J Cancer 121: 621-632.
27. Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, Raab S, Sherman M, Wilbur D, Wright T, Jr., Young N, Forum Group Members, Bethesda 2001 Workshop. 2002. The 2001 Bethesda System: Terminology for reporting results of cervical cytology. JAMA 287: 2114-2119.
28. Stevens MP, Garland SM, Rudland E, Tan J, Quinn MA, Tabrizi SN. 2007. Comparison of the Digene Hybrid Capture 2 assay and Roche AMPLICOR and LINEAR ARRAY human papillomavirus (HPV) tests in detecting high-risk HPV genotypes in specimens from women with previous abnormal Pap smear results. J Clin Microbiol 45: 2130-2137.
29. Wheeler CM, Hunt WC, Joste NE, Key CR, Quint WG, Castle PE. 2009. Human papillomavirus genotype distributions: Implications for vaccination and cancer screening in the United States. J Natl Cancer Inst 101: 475-487.
30. WHO/ICO Information Centre on HPV and Cervical Cancer. 2007. HPV and cervical cancer in the 2007 report. Vaccine 25: C1-C230.